Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-07 @ 5:46 AM
Study NCT ID:
NCT02359851
Status:
TERMINATED
Last Update Posted:
2019-09-18
First Post:
2015-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Advanced Uveal Melanoma
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2017-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-04
First Submit QC Date:
None
Study First Post Date:
2015-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-07
Results First Submit QC Date:
None
Results First Post Date:
2018-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-03
Last Update Post Date:
2019-09-18
Last Update Post Date Type:
ACTUAL